The efficacy of high-dose celecoxib (800/400 mg) was comparable to that of indomethacin (50 mg tid)
As these drugs already slow the movement of food through the digestive system, appropriate fibre intake can help prevent constipationone of the commonly reported adverse effects
Important considerations for ongoing management: Your prescriber may need to adjust your dose, switch to an alternative GLP-1 medicine, or investigate other potential causes of digestive symptoms

However, adjustments may be considered if: Glycaemic targets are not achieved : Your doctor may increase to the next available dose strength Intolerable side effects persist : A temporary dose reduction or slower titration may be appropriate Weight loss plateaus (for weight management indications): Dose optimisation may be discussed Renal function changes : Monitoring may be increased, though most GLP-1s don't require dose adjustment Other medications are added or removed : Particularly other glucose-lowering agents Important considerations during dose changes: Never skip doses or double up if you miss an injectionfollow the specific guidance in your patient information leaflet For missed doses, each product has different instructions: Semaglutide (Ozempic/Wegovy): If within 5 days, take as soon as possible

Food and Beverage Companies Beginning to Target GLP-1 Users Healthy Snacks & Small Meals Nestl and Kelloggs have reportedly started looking into snack products with lower calorie counts and high nutritional density
COVID-19 RISK and Treatments (CORIST) Collaboration